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Abstract. In clinical trials, the main purpose is often to compare efficacy between experimental and control treatments. 
Treatment comparisons often involve multiple endpoints, and this situation further complicates the analysis of survival 
data. In the case of tumor patients, endpoints concerning survival times include: times from tumor removal until the first, 
the second and the third tumor recurrences, and time to death. For each patient, these endpoints are correlated, and the 
estimation of the correlation between two score statistics is fundamental in derivation of overall treatment advantage. In 




In clinical trials, treatment comparisons often involve multiple responses or endpoints, and this situation further 
complicates the analysis of survival data. In the case of tumor patients, endpoints concerning survival times include: 
times from tumor removal until the first, the second and the third tumor recurrences, and time to death. For each 
patient, these endpoints are correlated, and the estimation of the correlation between two score statistics is 
fundamental in derivation of overall treatment advantage. In survival analysis, the logrank test [1] is one of the most 
popular methods for testing the equality of two treatment groups. It is routinely used in the analysis of clinical trials 
comparing the time-to-event distribution of a group of patients randomised to an experimental treatment with that of 
a control group. When prognostic factors are to be adjusted for, Cox’s proportional hazards regression [2], which is 
a direct generalisation of the logrank test, is commonly employed.  
This paper explores the potential of extending the bivariate survival analysis method to multivariate setting using 
the global score test methodology. Global test methodology has been used successfully in major clinical trials 
involving binary data with multiple outcomes. Its ability to provide a single parameter of treatment advantage, ease 
of interpretation, and reduced trial size has attracted researchers in stroke studies. Similarly, in cases involving 
multiple survival endpoints where the magnitude of the overall treatment advantage is of interest, the parameter is 
the log hazard ratio denoted by θ. The estimation of the correlation between the score statistics is crucial in adopting 
the global score test. Such estimation has been successfully developed for binary or ordered categorical data by 
Whitehead et al. [3]. An established method for combining multiple survival analyses is the Wei, Lin and Weissfeld 
[4], which involves fitting data to Cox’s regression model, and then adjusting the estimated variance of the 
coefficients.  Alternatively, Zain and Whitehead [5] has derived the estimation of the correlation between two score 
statistics and successfully applied to recurrent events data of patients with bladder cancer. Their estimation method 
for bivariate case will be explored for multivariate setting in this paper. 
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The next section briefly reviews the multivariate survival data structure, and is followed by the key concepts of 
the global score test methodology. Next, simple derivations for bivariate cases are stated, setting stage for the 
multivariate cases. The summary section concludes this concept paper and lays out the next steps and further works 
as well as potential applications. 
 
MULTIVARIATE SURVIVAL DATA  
 
Multivariate survival data involves two or more endpoints which cannot be assumed to be independent, and the 
measure of dependence or association of these variables is of interest. The multivariate data structures can be 
classified into parallel and longitudinal. For parallel data, the number of times is fixed by design, while for 
longitudinal, a random number of times is allowed. An example of the former is when several items (individuals or 
units) are observed simultaneously, such as the set of lifetimes of a set of twins or triplets. Longitudinal data concern 
continuous observation on the same item, such as tumor recurrences upon surgical removal.  
The complexity of studies concerning such correlated times-to-event which may involve multiple endpoints on 
the same subject, requires methods to take into account the correlation between multiple endpoints. For such data, 
the correlation between two score statistics can be used to obtain an overall treatment efficacy. In dealing with 
correlated survival outcomes in cross-over trials, fixed effects models can be applied by fitting Cox’s proportional 
hazards regression model stratified by subject. However, in parallel group trials where patients are randomized to 
experimental and control treatments, these methods fail. To overcome this difficulty, recourse can be made to one of 
two methods, namely marginal and frailty modelling. Marginal modelling involves fitting data to Cox’s regression 
model without any assumption of correlation, and then adjusting the estimated variance of the coefficients. A frailty 
model is a random effects model for event time data where subject effects are modelled as random variables [6]. 




GLOBAL SCORE TEST METHODOLOGY  
 
Global test methodology can be defined as the use of a combined model to estimate a composite measure of 
treatment effect concerning multiple outcomes. A global null hypothesis, that the treatment has no effect on any of a 
number of patient responses, is tested. Among applications of the global test methodology are the NINDS t-PA 
Stroke Trial [7] and the International Citicoline Trial in acUte Stroke [8]. In comparison of treatment effects, an 
essential sample statistic is the cumulative measure of the advantage of the experimental treatment, denoted by Z. Its 
companion, V, indicates the amount of information about the treatment advantage, θ, contained in Z. Statistically 
termed as the efficient score statistic, and Fisher’s information, Z and V, respectively, they can be computed at any 
stage of a clinical trial.  
In cases involving bivariate survival endpoints where the magnitude of the overall treatment advantage is of 
interest, the parameter is the log hazard ratio denoted by θ. The estimated common treatment advantage is given by 
1 1 2 2
ˆ ˆ ˆw w  where w is some weighting with subscripts 1 and 2 for the 1st and 2nd events respectively, and w1 + 
w2 = 1. Using the same concept, the ZW method can be further extended to accommodate multivariate setting of 
more than two survival times. Suppose that three survival times, T1, T2, T3, concern a patient. The estimated 
treatment advantage is now, , where the subscript 3 indicates belonging to the 3rd event, 
and w1 + w2 + w3 = 1. For independent endpoints, the weighting is simply the ratio of the Fisher’s information, V to 
the sum of V; for instance, , and similarly for the other counterparts corresponding to the 2nd and 3rd 
endpoints. However, when endpoints are correlated, an optimal weighting [9], which yields the smallest variance out 
of all weighted averages of θ1, θ2 and θ3, is used.  
To measure the dependence structure, the covariance between pairs of score statistics and hence their correlation 
are estimated, and this holds the key to the application of global score test methodology.  
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CORRELATION ESTIMATOR 
 
Using the global score test methodology, Zain and Whitehead [10] have also discussed cases of time-to-
progression (TTP) and progression-free-survival (PFS) in relation to the overall survival (OS). Adopting the same 
methodology, Zain et al. [11] have analyzed real data of colorectal cancer patients in Malaysia. The bivariate 
survival data were categorized into multiple intervals and the score statistic Z and Fisher’s information, V, were 
derived from complementary log-log approach. The covariance of each pair of intervals, C12(ij) was derived directly, 
involving the marginal data given by interval of individual event and the paired intervals of both events. 
Conditioning on successive risk sets, the covariance between two score statistics, cov(Z1, Z2) was obtained by the 
summation of covariance from each pair of intervals, and denoted by C12. Accordingly, the correlation ρ between 
these two score statistics were estimated by 12 1 2ˆ / .C VV  The detailed derivation can be referred to the complete 
work of Zain & Whitehead [4], abbreviated as ZW method. Further explanation on the underlying theories shall be 
read in thorough from the original work by Zain [12]. 
In multivariate setting, suppose three survival times, T1, T2, T3, concerning a patient, are correlated, thus the 
cov(Z1, Z3) is obtained by the summation of covariance from each pair of intervals concerning T1 and T3, and is 
denoted by C13, and the correlation ρ can be estimated by  . Similar expressions can be derived for 
the estimators related to T2 and T3, accordingly. The three sets of covariance values can then be used to estimate their 
corresponding correlations as well as the variance of treatment advantage, var(  the weightings, and ultimately 
the overall  The value of   is the single statistical measure of treatment advantage, simplified for multivariate 




Following its success in categorical and binary data, global score test methodology has recently been used 
successfully in bivariate survival analysis [5, 10, 11]. Theoretically, the method of ZW for bivariate cases shall work 
for multivariate cases involving more than two survival times. Comparison with the WLW method and simulation 
study shall be conducted to prove its workability and accuracy accordingly. Meanwhile, its application should 
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